Annual Gross Margin
N/A
December 1, 2023
Summary
- CAMP annual gross profit margin is not available.
Performance
CAMP Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Gross Margin
N/A
September 1, 2024
Summary
- CAMP quarterly gross profit margin is not available.
Performance
CAMP Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
CAMP Gross Margin Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | - |
3 y3 years | - | - |
5 y5 years | - | - |
CAMP Gross Margin Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time |
CAMP4 Therapeutics Gross Margin History
Date | Annual | Quarterly |
---|---|---|
Nov 2023 | - | 32.77%(-9.5%) |
Aug 2023 | - | 36.21%(-5.1%) |
May 2023 | - | 38.17%(+8.0%) |
Feb 2023 | - | 35.33%(+4.7%) |
Feb 2023 | 36.96%(-10.3%) | - |
Nov 2022 | - | 33.74%(-15.3%) |
Aug 2022 | - | 39.84%(+0.6%) |
May 2022 | - | 39.62%(-3.4%) |
Feb 2022 | 41.20%(+3.9%) | 41.02%(+0.7%) |
Nov 2021 | - | 40.74%(-3.5%) |
Aug 2021 | - | 42.23%(+3.7%) |
May 2021 | - | 40.72%(-3.6%) |
Feb 2021 | 39.67%(+1.7%) | 42.22%(+6.1%) |
Nov 2020 | - | 39.79%(+7.8%) |
Aug 2020 | - | 36.91%(-6.5%) |
May 2020 | - | 39.47%(+9.0%) |
Feb 2020 | 39.00%(-3.5%) | 36.22%(-5.1%) |
Nov 2019 | - | 38.18%(-5.5%) |
Aug 2019 | - | 40.40%(+1.6%) |
May 2019 | - | 39.76%(+10.2%) |
Feb 2019 | 40.41%(-2.0%) | 36.07%(-12.3%) |
Nov 2018 | - | 41.11%(-0.8%) |
Aug 2018 | - | 41.46%(+3.3%) |
May 2018 | - | 40.14%(-1.4%) |
Feb 2018 | 41.24%(+1.0%) | 40.70%(-0.2%) |
Nov 2017 | - | 40.77%(-0.7%) |
Aug 2017 | - | 41.04%(-3.5%) |
May 2017 | - | 42.51%(+2.3%) |
Feb 2017 | 40.83%(+11.3%) | 41.55%(-1.4%) |
Nov 2016 | - | 42.13%(+1.3%) |
Aug 2016 | - | 41.57%(+8.8%) |
May 2016 | - | 38.22%(-1.8%) |
Feb 2016 | 36.68%(+5.2%) | 38.92%(+9.4%) |
Nov 2015 | - | 35.59%(-1.8%) |
Aug 2015 | - | 36.25%(+0.8%) |
May 2015 | - | 35.96%(+1.2%) |
Feb 2015 | 34.88%(+3.0%) | 35.53%(+1.6%) |
Nov 2014 | - | 34.96%(+1.0%) |
Aug 2014 | - | 34.62%(+1.0%) |
May 2014 | - | 34.28%(-0.5%) |
Feb 2014 | 33.88%(+7.5%) | 34.45%(+4.2%) |
Nov 2013 | - | 33.06%(-2.0%) |
Aug 2013 | - | 33.74%(-1.9%) |
May 2013 | - | 34.39%(+10.6%) |
Feb 2013 | 31.51%(+4.0%) | 31.10%(-1.7%) |
Nov 2012 | - | 31.65%(-1.5%) |
Aug 2012 | - | 32.13%(+3.0%) |
May 2012 | - | 31.18%(+10.7%) |
Feb 2012 | 30.29%(+17.2%) | 28.16%(-9.3%) |
Nov 2011 | - | 31.05%(-11.2%) |
Aug 2011 | - | 34.98%(+28.1%) |
May 2011 | - | 27.30%(-5.6%) |
Feb 2011 | 25.85%(+29.4%) | 28.91%(+11.0%) |
Nov 2010 | - | 26.05%(+4.3%) |
Aug 2010 | - | 24.98%(+7.5%) |
May 2010 | - | 23.24%(+14.8%) |
Feb 2010 | 19.97%(-48.5%) | 20.25%(+5.4%) |
Nov 2009 | - | 19.21%(-4.3%) |
Aug 2009 | - | 20.07%(-2.0%) |
May 2009 | - | 20.47%(-67.9%) |
Feb 2009 | 38.76%(+195.2%) | 63.71%(+115.4%) |
Nov 2008 | - | 29.58%(-7.7%) |
Aug 2008 | - | 32.04%(-5.2%) |
May 2008 | - | 33.79%(+33.5%) |
Feb 2008 | 13.13%(-40.9%) | 25.31%(-19.1%) |
Nov 2007 | - | 31.28%(+61.8%) |
Aug 2007 | - | 19.33%(-266.5%) |
May 2007 | - | -11.61%(-152.2%) |
Feb 2007 | 22.22% | 22.26%(+9.3%) |
Nov 2006 | - | 20.37%(-12.1%) |
Date | Annual | Quarterly |
---|---|---|
Aug 2006 | - | 23.17%(-1.8%) |
May 2006 | - | 23.59%(-7.3%) |
Feb 2006 | 24.25%(+28.9%) | 25.46%(-0.3%) |
Nov 2005 | - | 25.54%(+9.8%) |
Aug 2005 | - | 23.27%(+3.5%) |
May 2005 | - | 22.48%(+21.2%) |
Feb 2005 | 18.81%(+36.9%) | 18.55%(+2.8%) |
Nov 2004 | - | 18.05%(-11.1%) |
Aug 2004 | - | 20.31%(+10.1%) |
May 2004 | - | 18.45%(+19.4%) |
Feb 2004 | 13.74%(-33.0%) | 15.45%(+1.5%) |
Nov 2003 | - | 15.22%(+15.1%) |
Aug 2003 | - | 13.22%(+88.1%) |
May 2003 | - | 7.03%(-53.7%) |
Feb 2003 | 20.52%(-9.7%) | 15.17%(-17.0%) |
Nov 2002 | - | 18.27%(-20.9%) |
Aug 2002 | - | 23.09%(-11.2%) |
May 2002 | - | 25.99%(+32.8%) |
Feb 2002 | 22.72%(+15.7%) | 19.57%(-15.1%) |
Nov 2001 | - | 23.04%(-7.7%) |
Aug 2001 | - | 24.95%(-12.6%) |
May 2001 | - | 28.54%(+60.6%) |
Feb 2001 | 19.64%(-18.5%) | 17.77%(-17.8%) |
Nov 2000 | - | 21.61%(+12.4%) |
Aug 2000 | - | 19.22%(-20.1%) |
May 2000 | - | 24.05%(+142.7%) |
Feb 2000 | 24.10%(-33.3%) | 9.91%(-65.3%) |
Nov 1999 | - | 28.52%(-13.0%) |
Aug 1999 | - | 32.80%(-4.4%) |
May 1999 | - | 34.32%(-2.0%) |
Feb 1999 | 36.11%(+21.0%) | 35.01%(-5.7%) |
Nov 1998 | - | 37.11%(+14.1%) |
Aug 1998 | - | 32.53%(-17.8%) |
May 1998 | - | 39.56%(+202.0%) |
Feb 1998 | 29.85%(-10.8%) | 13.10%(-52.6%) |
Nov 1997 | - | 27.61%(-24.6%) |
Aug 1997 | - | 36.64%(-0.1%) |
May 1997 | - | 36.67%(+117.6%) |
Feb 1997 | 33.47%(-13.0%) | 16.85%(-53.1%) |
Nov 1996 | - | 35.90%(-1.7%) |
Aug 1996 | - | 36.52%(-7.1%) |
May 1996 | - | 39.31%(+1.7%) |
Feb 1996 | 38.47%(+4.7%) | 38.67%(+1.7%) |
Nov 1995 | - | 38.04%(-1.5%) |
Aug 1995 | - | 38.62%(+2.2%) |
May 1995 | - | 37.80%(-5.5%) |
Feb 1995 | 36.76%(+12.5%) | 40.00%(+6.4%) |
Nov 1994 | - | 37.61%(+11.8%) |
Aug 1994 | - | 33.63%(+17.7%) |
May 1994 | - | 28.57%(-5.4%) |
Feb 1994 | 32.68%(-13.3%) | 30.19%(-4.4%) |
Nov 1993 | - | 31.58%(-5.3%) |
Aug 1993 | - | 33.33%(-3.7%) |
Feb 1993 | 37.71%(-7.5%) | 34.62%(+1.6%) |
Nov 1992 | - | 34.09%(-20.5%) |
Aug 1992 | - | 42.86%(+4.6%) |
May 1992 | - | 40.96%(+14.3%) |
Feb 1992 | 40.78%(+66.6%) | - |
Aug 1991 | - | 35.85%(-5.3%) |
May 1991 | - | 37.84%(+13.5%) |
Feb 1991 | 24.48%(-23.8%) | 33.33%(+153.3%) |
Nov 1990 | - | 13.16%(-55.7%) |
Aug 1990 | - | 29.73%(+4.1%) |
May 1990 | - | 28.57% |
Feb 1990 | 32.11%(+12.4%) | - |
Feb 1989 | 28.57%(-28.6%) | - |
Feb 1988 | 40.00%(-16.8%) | - |
Feb 1987 | 48.05%(-639.9%) | - |
Feb 1986 | -8.90%(-152.9%) | - |
Feb 1985 | 16.84%(-64.7%) | - |
Feb 1984 | 47.68% | - |
FAQ
- What is the all time high annual gross margin for CAMP4 Therapeutics?
- What is the all time high quarterly gross margin for CAMP4 Therapeutics?
What is the all time high annual gross margin for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high annual gross profit margin is 48.05%
What is the all time high quarterly gross margin for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high quarterly gross profit margin is 63.71%